Management Team
Director, President and Chief Executive Officer, Chair of the Board
Gary S. Gillheeney, Sr. has served as our President and Chief Executive Officer since 2014. Previously, he served as our Executive Vice President, Chief Operating Officer and Chief Financial Officer from 2003 to 2014 and as our Chief Financial Officer from 2002 to 2003.
Chief Operating Officer
Patrick Bilbo has served as our Chief Operating Officer since 2017. Previously, he served as our Senior Vice President, Regulatory, Government Affairs and Administration and other executive positions from 1999 to 2017. Prior to joining Organogenesis, he was Director, Regulatory and Clinical
Chief Financial Officer
David C. Francisco has served as Chief Financial Officer since 2021. Prior to joining Organogenesis, Mr. Francisco spent 20 years at PerkinElmer, Inc. (NYSE: PKI), a leading provider of products, services and solutions for the diagnostics, life sciences and applied markets with over $3.5 billion in
Chief Administrative and Legal Officer
Lori Freedman has served as our Chief Administrative and Legal Officer since 2023. She joined Organogenesis in 2017 and had served as Vice President and General Counsel since 2018. Previously, she served as Vice President, Corporate Affairs & General Counsel of pSivida Corp., a specialty
Chief Commercial Officer
Brian Grow has served as our Chief Commercial Officer since 2017. Since 2004, he has served in a number of roles at Organogenesis with increasing responsibility, including as our Director of Sales, Commercial Operations, from 2013 to 2016, Associate Director, Marketing, from 2012 to 2013, Project